AdaptHealth former CFO proposes $1.26M share sale

A separate count gives 136,525,348 common shares outstanding.

Available on EDGAR 11/05/2026 - 04:13 PM EST Accepted by SEC EDGAR 11/05/2026 - 04:13 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

AdaptHealth Corp. former CFO Jason Allen Clemens gave notice of a proposed sale of 169,779 common shares, with a reported aggregate market value of $1,260,743.41 and an approximate sale date of November 5, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The acquisition entries describe restricted-stock vesting under a registered plan.

Key Figures

Common shares proposed for sale: 169,779 shares Aggregate market value: $1,260,743.41 Common shares outstanding: 136,525,348 shares

3 metrics

Common shares proposed for sale 169,779 shares Approximate sale date: November 5, 2026

Aggregate market value $1,260,743.41 Proposed common-share sale

Common shares outstanding 136,525,348 shares Outstanding-share count listed

Key Terms

Rule 144, Restricted Stock Vesting Under a Registered Plan, Aggregate market value

3 terms

Rule 144 regulatory

"sales required by paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting Under a Registered Plan financial

"Restricted Stock Vesting Under a Registered Plan"

Aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AHCO shares did Jason Allen Clemens propose to sell?

The proposed sale is for 169,779 common shares, with a reported aggregate market value of $1,260,743.41.

How many AHCO common shares are listed as outstanding?

The listed outstanding count is 136,525,348 common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001820867
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ADAPTHEALTH CORP.
SEC File Number	001-38399
Address of Issuer	555 East North Lane Suite 5075 Conshohocken PENNSYLVANIA 19428
Phone	(610) 424-4515
Name of Person for Whose Account the Securities are To Be Sold	JASON A CLEMENS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former CFO

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	169779	1260743.41	136525348	11/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/13/2022	Restricted Stock Vesting Under a Registered Plan	Issuer			19806	07/13/2022	Services Rendered
Common	12/01/2021	Restricted Stock Vesting Under a Registered Plan	Issuer			1300	12/01/2021	Services Rendered
Common	02/01/2023	Restricted Stock Vesting Under a Registered Plan	Issuer			686	02/01/2023	Services Rendered
Common	02/01/2024	Restricted Stock Vesting Under a Registered Plan	Issuer			8410	02/01/2024	Services Rendered
Common	02/01/2024	Restricted Stock Vesting Under a Registered Plan	Issuer			8555	02/01/2024	Services Rendered
Common	01/01/2024	Restricted Stock Vesting Under a Registered Plan	Issuer			4567	01/01/2024	Services Rendered
Common	10/11/2023	Restricted Stock Vesting Under a Registered Plan	Issuer			7560	10/11/2023	Services Rendered
Common	02/01/2026	Restricted Stock Vesting Under a Registered Plan	Issuer			33047	02/01/2026	Services Rendered
Common	02/01/2026	Restricted Stock Vesting Under a Registered Plan	Issuer			7924	02/01/2026	Services Rendered
Common	03/18/2025	Restricted Stock Vesting Under a Registered Plan	Issuer			24046	03/18/2025	Services Rendered
Common	02/01/2026	Restricted Stock Vesting Under a Registered Plan	Issuer			29751	02/01/2026	Services Rendered
Common	03/18/2026	Restricted Stock Vesting Under a Registered Plan	Issuer			24127	03/18/2026	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jason Allen Clemens
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)